Editorial · 2012
EditorialPublished 2 Aug 2020
The Complexity of Alzheimerâ??s Disease Pharmacogenomics and Metabolomics in Drug Development
Keywords
Subjects
Biochemistry & BiotechnologySimilar by topic
Short communication · 2021
Brain Metabolomics Study on the Protective Effects of Ginsenosides Rg1 and Rb1 in an Alzheimerâ??s Disease Mouse Model
Article · 2014
The Pathogenic Component of the APOE-TOMM40 Region in Alzheimerand#8217;s Disease: Its Implications in Metabolomics and Pharmacogenomics
Editorial · 2014
The Pathogenic Component of the APOE-TOMM40 Region in Alzheimer’s Disease: Its Implications in Metabolomics and Pharmacogenomics
Brief report · 30 Sep 2024
Decoding Biological Complexity: The Power of Metabolomic Analysis in Disease Research
More from this journal
The newest in Metabolomics:Open Access.
Brief report · 29 Dec 2025
Metabolomics Databases Evolve: Broader Scope, Deeper Insights
Perspective · 29 Dec 2025
Metabolomics: Assessing Environmental Health and Risk
Brief report · 29 Dec 2025
Metabolite Quantification: Accuracy, Standards, Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMetabolomics:Open Access
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Ramon Cacabelos”

